KURARAY (3405) FY2026 Q2 Earnings Report

Quick View

Executive Summary

Kuraray’s FY2026 Q2 results recorded increases in both revenue and profit, although the growth in net income was limited and variation was observed in earnings quality. Revenue was ¥4310.4B (+7.8% YoY), operating income was ¥288.4B (+9.8%), ordinary income was ¥259.8B (+22.1%), and net income was ¥151.7B (+8.1%). Revenue growth was driven by double-digit growth in the Functional Materials and Isoprene businesses in addition to the core Vinyl Acetate business. Ordinary income grew faster than operating income due to a reduction in non-operating expenses, while the recognition of extraordinary losses constrained net income growth.

Factors Affecting Performance

【Revenue】Revenue increased 7.8% YoY to ¥4310.4B, with all segments recording revenue growth. High-growth businesses, including Functional Materials (+12.0%), Isoprene (+14.9%), and Trading (+10.1%), lifted overall performance, while the core Vinyl Acetate business also remained solid with growth of +7.0%. Meanwhile, the Other category declined 27.3%.

【Profit and Loss】Operating income increased 9.8% YoY to ¥288.4B, supported by a gross margin of 29.9% (improved YoY), although the SG&A ratio rose slightly to 23.2%, partially offsetting the benefit of higher revenue. By segment, operating income in Functional Materials improved significantly to ¥48.8B (+184.9%), while Fibers also recovered sharply from the low level recorded in the previous year to ¥42.0B. In contrast, the core Vinyl Acetate business reported operating income of ¥253.8B (-15.0%), with its margin declining to 11.7%, weighing on company-wide profitability. Ordinary income increased 22.1% to ¥259.8B, exceeding operating income growth due to lower non-operating expenses. However, net income was limited to ¥151.7B (+8.1%) following the recognition of extraordinary losses of ¥44.1B. Revenue and profit both increased.

Segment Analysis

By segment, the core Vinyl Acetate business accounted for approximately 6割 of total company profit, with operating income of ¥253.8B (-15.0% YoY) and a profit margin of 11.7%, although its margin declined from the previous year. In contrast, Functional Materials reported ¥48.8B (+184.9%, profit margin 4.4%), Isoprene reported ¥17.9B (+236.4%, profit margin 3.9%), and Fibers reported ¥42.0B (profit margin 13.2%), confirming significant improvements in profitability. Trading continued to deliver stable growth, with operating income of ¥36.7B (+20.7%). The decline in the margin of Vinyl Acetate, which has a high concentration of company-wide profit, has been partially offset by the diversification effect arising from the recovery of Functional Materials and other businesses.

Key Financial Indicators

【Profitability】The operating margin was 6.7%, the gross margin was 29.9%, and the SG&A ratio was 23.2%. As SG&A expenses increased proportionately with revenue, operating leverage remained limited. ROE remained low at 2.0%. 【Cash Flow Quality】Operating Cash Flow (OCF) was ¥590.3B, approximately 3.9 times net income of ¥151.7B, indicating strong cash backing for earnings. 【Investment Efficiency】The equity ratio was 56.9%, and basic EPS was ¥46.98 (+8.0% from ¥43.50 in the previous year). 【Financial Soundness】Current assets of ¥6062.4B compared with current liabilities of ¥2306.8B provide a substantial short-term liquidity cushion. Long-term borrowings were ¥1771.3B and bonds were ¥500.0B, indicating increased use of long-term funding.

Cash Flow Analysis

Operating Cash Flow was ¥590.3B, a substantial 40.0% increase YoY, indicating strong cash backing for earnings after taking into account depreciation and amortization of ¥421.8B. Investing Cash Flow was -¥560.3B, apparently centered on investments in property, plant and equipment and intangible assets, reflecting an aggressive capital investment stance. As a result, free cash flow was limited to ¥30.0B, indicating that investment outlays preceded and compressed cash-generation capacity. Financing Cash Flow was positive at ¥138.1B, although ¥100.0B was allocated to share repurchases, suggesting that shareholder returns were implemented alongside external funding. In terms of working capital, accounts payable declined by ¥59.3B, acting as a partial downward pressure on cash flow.

Earnings Quality

The core source of recurring earnings was operating income of ¥288.4B, which was steadily generated by business operations. At the same time, extraordinary gains of ¥29.4B, including gains on the sale of investment securities of ¥11.8B, and extraordinary losses of ¥44.1B were recognized, creating a temporary net factor weighing on net income. Non-operating expenses of ¥62.9B, including interest expenses of ¥18.7B, exceeded non-operating income such as interest income of ¥10.4B and dividend income of ¥4.2B, resulting in a net negative balance. Operating Cash Flow reached approximately 3.9 times net income, indicating high-quality earnings that do not depend on accruals (accounting estimates). The divergence between ordinary income and net income was attributable to the ¥93.5B tax burden and the impact of extraordinary losses.

Earnings Forecast and Guidance

The full-year plan calls for revenue of ¥8800.0B, operating income of ¥700.0B, and ordinary income of ¥640.0B, with double-digit YoY growth expected for all three items. As of the first half, progress rates were 49.0% for revenue, 41.2% for operating income, and 40.6% for ordinary income. Revenue is generally on track with the plan, while profit progress is somewhat behind. The delayed profit progress appears to have been caused by the decline in the margin of the core Vinyl Acetate business, making the trend in profitability improvement toward the second half a key factor in achieving the plan. Although the earnings forecast was revised during the quarter, there was no revision to the dividend forecast.

Shareholder Returns

The interim dividend was ¥32 (+18.5% YoY), and the full-year dividend forecast is ¥64. Based on net income, the payout ratio is approximately 63.9%, calculated using total dividends of approximately ¥96.9B corresponding to the interim dividend of ¥32 against first-half net income of ¥151.7B. In addition, ¥100.0B was allocated to share repurchases, resulting in a high total return ratio of approximately 129.4% relative to first-half net income when dividends and share repurchases are combined. Total shareholder returns exceeded free cash flow of ¥30.0B, indicating that retained earnings and external funding are increasingly being used as sources of shareholder returns; this requires monitoring.

Risk Factors

1. Risk of margin pressure in the core business: Operating income in Vinyl Acetate was ¥253.8B, down -15.0% YoY, and its profit margin declined to 11.7%. Given the high concentration of company-wide profit in this business, fluctuations in market conditions and raw material and fuel prices could have a significant impact on overall performance.

2. Risk of cash flow compression from front-loaded investment: Investing Cash Flow was substantial at -¥560.3B, leaving free cash flow at only ¥30.0B. As capital investment continues, the pace of investment recovery will influence future cash-generation capacity.

3. Risk regarding the sustainability of shareholder returns: The combined amount of dividends and share repurchases substantially exceeded free cash flow of ¥30.0B. Maintaining the current level of returns will require further growth in Operating Cash Flow or improvement in asset efficiency.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability, as measured by both operating margin and net margin, is below the industry median, placing it at a disadvantage in terms of profitability relative to the manufacturing industry average.

Growth and Capital Efficiency

The revenue growth rate also fell slightly below the industry median, placing the company’s revenue growth below the mid-range within the industry.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. The decline in the margin of the core Vinyl Acetate business—operating margin of 11.7% and operating income down -15.0% YoY—has weighed on company-wide profitability. The structure indicates that the recovery in profitability of Functional Materials, Isoprene, and Fibers is diversifying and offsetting this pressure.

2. Operating Cash Flow was ¥590.3B, up +40.0% YoY, providing strong support for earnings. However, Investing Cash Flow reached -¥560.3B, leaving free cash flow thin at ¥30.0B. The fact that total shareholder returns, including dividends and share repurchases, exceeded free cash flow is noteworthy from a capital allocation perspective.

3. First-half progress against the full-year plan was 49.0% for revenue, compared with 41.2% for operating income and 40.6% for ordinary income. Profit progress is somewhat behind, making the extent of profitability improvement in the core business during the second half a key determinant of whether the plan will be achieved.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥2,230–¥2,359 at cost of equity ±1%, and ¥2,285–¥2,299 at ω±0.1.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This value does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Kuraray delivered a solid first-half FY2026 operating performance, although conversion of earnings into shareholder returns is constrained by a heavy investment cycle and weak capital efficiency. Revenue increased 7.8% year on year to ¥431.0bn, while operating income rose faster by 9.8% to ¥28.8bn. The operating margin expanded by 10bp to 6.7%, from approximately 6.6% a year earlier, indicating modest positive operating leverage. Gross profit increased 9.5% to ¥129.0bn and the gross margin improved by 40bp to 29.9%. SG&A rose 9.4% to ¥100.1bn, modestly above revenue growth, which limited the extent of operating-margin expansion. Ordinary income grew 22.1% to ¥26.0bn, benefiting from a lower net non-operating expense burden than in the prior year. Profit attributable to owners increased only 1.4% to ¥14.2bn, materially lagging operating and ordinary profit growth. The main constraint was a higher effective tax rate of 38.1%, with the DuPont tax burden at 0.580. Operating cash flow of ¥59.0bn was 4.15 times consolidated net income and exceeded EBITDA cash conversion of 0.83 times, supporting the underlying cash realization of earnings. However, investing cash outflow of ¥56.0bn nearly absorbed operating cash flow, leaving first-half free cash flow of only ¥3.0bn. Capital expenditure and intangible-asset purchases of ¥54.7bn were above ¥45.2bn in the prior period, while construction in progress reached ¥116.9bn, or 20.4% of PPE. Liquidity remains strong, with a 262.8% current ratio, ¥122.1bn of cash, and cash equal to 2.22 times short-term debt. Balance-sheet leverage remains manageable at 0.76 times debt to equity and 23.2% debt to capital, although debt/EBITDA of 3.27 times reflects the funding requirement of the investment program. The Vinyl Acetate segment remains the core earnings contributor, generating ¥25.4bn of segment profit, but its profit declined 15.0% despite sales growth. Management's full-year forecast implies second-half acceleration, particularly for operating profit, and the disclosed forecast revision indicates that assumptions have been updated. The investment case therefore hinges on whether the current construction pipeline and Functional Materials growth can lift returns above the currently low 4.1% ROIC while working-capital intensity improves.

Profitability Analysis

The reported annualized DuPont ROE is 3.7%, composed of a 3.3% net profit margin, 0.638x annualized asset turnover, and 1.76x financial leverage. The weakest component is the net margin, which remains below the 5% benchmark despite the 6.7% EBIT margin and 16.5% EBITDA margin. Financial leverage is moderate rather than aggressive, so the low ROE principally reflects limited operating return and asset productivity rather than overleveraging. The annualized asset turnover of 0.638x is consistent with a capital-intensive chemical manufacturer, but ¥571.6bn of PPE and the enlarged construction pipeline require higher future operating profit to earn an adequate return. The 5-factor analysis shows a 0.850 interest burden, which is acceptable, while interest coverage of 15.4x and EBITDA interest coverage of 37.9x show that financing costs are currently well covered. The tax burden of 0.580 is the most material drag in the extended DuPont chain; the effective tax rate calculated from profit before tax is 38.1%. The HIGH_TAX_BURDEN alert is therefore relevant because the tax burden is below 0.60, meaning only 58% of pre-tax income converted into consolidated net income; this reduces ROE and makes modest operating gains less visible at the bottom line. The reported effective rate is 38.1%, so the principal issue is elevated tax drag rather than interest expense. Operating leverage was mildly favorable: revenue grew 7.8%, gross profit 9.5%, and operating profit 9.8%. Yet SG&A increased 9.4%, faster than sales, reflecting increased administrative and selling costs and higher unallocated corporate costs, which rose to ¥10.7bn from ¥10.0bn. This cost trend bears monitoring because further SG&A growth above revenue would prevent gross-margin gains from translating into material EBIT-margin expansion. Under JGAAP, goodwill amortization can depress operating income relative to IFRS comparables; nevertheless, reported goodwill is only 0.72x EBITDA and 6.6% of equity, so M&A accounting does not appear to be a dominant distortion of profitability.

Growth Assessment

Top-line growth was broad across the reported portfolio, with external sales rising to ¥431.0bn from ¥400.0bn. Vinyl Acetate remained the core business by segment profit contribution, delivering ¥207.9bn of external sales, up 7.3%, and ¥25.4bn of segment profit, down 15.0%; its segment margin declined to 12.2% from 15.4%. Isoprene sales increased 24.4% to ¥37.9bn and segment profit improved to ¥1.8bn from a ¥1.3bn loss, marking a meaningful earnings recovery. Functional Materials sales grew 12.5% to ¥108.4bn and segment profit increased 184.9% to ¥4.9bn, lifting its margin to 4.5% from 1.8%; this was the strongest profit-growth contributor. Fibers sales rose 5.9% to ¥29.2bn and segment profit turned to a ¥4.2bn profit from a ¥0.1bn loss, with margin improving to 14.4%. Trading sales increased 10.1% to ¥36.6bn and segment profit rose 20.7% to ¥3.7bn, producing a 10.0% margin. Other businesses recorded a sales decline of 40.9% to ¥10.9bn and segment profit fell 58.8% to ¥0.8bn. The improvement in Isoprene, Functional Materials and Fibers offset the Vinyl Acetate profit decline, while unallocated corporate costs increased by ¥0.7bn and moderated consolidated growth. Full-year sales guidance is ¥880.0bn, placing first-half progress at 49.0%, essentially in line with the 50% seasonal benchmark. Operating-income progress is 41.2% against the ¥70.0bn forecast, 8.8 percentage points below the standard first-half run rate, requiring ¥41.2bn of second-half operating profit. Ordinary-income progress is 40.6% against the ¥64.0bn forecast, also requiring a stronger second half. Profit attributable to owners is at 35.6% of the ¥40.0bn forecast, or ¥25.8bn needed in the second half, a 14.4 percentage point shortfall versus a 50% run rate. Accordingly, the forecast depends on a material second-half improvement in margin and/or non-operating and tax outcomes. The FY2026 forecast calls for sales growth of 8.9%, operating-income growth of 18.9%, and ordinary-income growth of 24.2%, implying that the company expects a more pronounced earnings recovery than the first-half operating margin alone demonstrates.

Financial Health

Financial health is sound from a liquidity perspective. Current assets of ¥606.2bn exceeded current liabilities of ¥230.7bn by ¥375.6bn, producing a 262.8% current ratio and a 185.9% quick ratio. Cash and deposits of ¥122.1bn cover short-term loans of ¥55.1bn by 2.22 times, reducing refinancing risk. Interest-bearing debt totaled ¥232.2bn, including ¥55.1bn of short-term loans and ¥177.1bn of long-term loans; the 23.7% short-term debt ratio indicates that the majority of debt has longer-duration funding. Current assets substantially exceed short-term debt, so there is no evident near-term maturity mismatch. Debt to equity of 0.76x, debt to capital of 23.2%, and total liabilities equal to 43.1% of assets indicate a moderate capital structure rather than excessive leverage. Debt/EBITDA of 3.27x is above the 2.5x investment-grade reference point but below the 4.0x high-yield warning threshold, leaving less balance-sheet flexibility while the investment program remains elevated. Long-term loans increased 21.2% year on year to ¥177.1bn and short-term loans increased 22.1% to ¥55.1bn, indicating that expansion spending is being partly debt-funded. Goodwill of ¥51.1bn equals only 3.8% of assets and 6.6% of equity, while intangible assets equal 8.1% of assets; these levels imply limited M&A-related impairment concentration. Defined-benefit liabilities of ¥32.7bn represent an additional long-duration obligation but are modest relative to ¥768.4bn of total equity.

Notable B/S Changes

Construction in progress: +¥20.2bn (+20.9%) to ¥116.9bn, reaching 20.4% of PPE; this evidences an elevated investment pipeline and raises execution and return-on-capital requirements. Long-term loans: +¥30.9bn (+21.2%) to ¥177.1bn; debt funding has increased alongside capital investment, though liquidity and interest coverage remain strong. Short-term loans: +¥10.0bn (+22.1%) to ¥55.1bn; short-term borrowings increased, but cash of ¥122.1bn remains 2.22x short-term debt. PPE: +¥22.5bn (+4.1%) to ¥571.6bn; the expanded fixed-asset base requires improved utilization and operating profit to raise ROIC. Cash and deposits: +¥18.0bn (+17.3%) to ¥122.1bn; cash accumulation supports near-term liquidity despite substantial capital outflows. Capital surplus: -¥10.0bn (-17.9%) to ¥45.9bn, consistent with the ¥10.0bn share-repurchase outflow and a reduction in equity reserves.

Cash Flow Quality

Cash-flow quality is favorable at the earnings-conversion level: operating cash flow was ¥59.0bn versus ¥15.2bn of consolidated net income, or 4.15x. The accruals ratio of negative 3.3% also supports cash-backed earnings rather than aggressive accrual recognition. EBITDA was ¥71.0bn and OCF/EBITDA was 0.83x, below the 0.9x excellent benchmark but still consistent with substantial conversion. Operating cash flow benefited from non-cash depreciation and amortization of ¥42.2bn, while movements in receivables were small and inventory increased by only ¥0.8bn during the half. The company nevertheless carries substantial working-capital intensity. The HIGH_RECEIVABLE_DAYS alert identifies annualized DSO of 77 days, above the 60-day warning level; slower collection ties up cash and could weaken conversion if sales growth decelerates. The HIGH_INVENTORY_DAYS alerts identify annualized DIO of 165 days and 107 days, both above their respective warning thresholds; for a chemical manufacturer, such elevated inventory duration raises exposure to demand changes, product mix shifts, and potential valuation pressure. Finished goods were ¥177.4bn, raw materials ¥73.5bn, and work in process ¥21.3bn, underscoring the importance of inventory management to cash generation. The LONG_CCC alert, at an annualized 209 days, is a material working-capital concern because cash is committed for an extended period between procurement and customer collection. This cycle is particularly relevant in manufacturing, where the core Vinyl Acetate segment experienced a profit decline despite revenue growth. Investing outflow was ¥56.0bn, including ¥54.7bn of purchases of PPE and intangibles, leaving only ¥3.0bn of first-half free cash flow. Thus, accounting earnings are cash-supported, but internally generated cash is presently almost fully consumed by investment. The HIGH_CIP alert is also material: construction in progress of ¥116.9bn is 20.4% of PPE, just above the 20% warning level, indicating a large project pipeline that carries commissioning, cost-overrun, and return-on-investment risk. The elevated CIP is understandable in a capital-intensive specialty-chemical business and rose 20.9% year on year, but delayed start-up or weak end-market demand would defer the expected cash return.

Dividend Sustainability

The interim dividend is ¥32 per share, equal to 67.9% of first-half EPS of ¥46.98. This interim payout is above the 60% sustainability reference point when assessed against first-half earnings alone. The full-year dividend forecast is ¥64 per share against forecast EPS of ¥132.76, implying a more moderate full-year payout ratio of approximately 48.2%. On that forecast basis, the ordinary dividend appears covered by expected accounting earnings. First-half free cash flow was only ¥3.0bn, whereas the ¥32 interim dividend implies approximately ¥9.7bn of shareholder cash distribution, resulting in 0.31x FCF coverage. The current dividend therefore relies on balance-sheet capacity and expected second-half cash generation rather than first-half FCF alone. Share repurchases totaled ¥10.0bn; including the interim dividend, the first-half total return is approximately ¥19.7bn, or roughly 130% of consolidated net income. This total return ratio exceeds the 100% warning level and, alongside heavy capital spending, limits retained cash for deleveraging. Strong liquidity and moderate D/E provide capacity to maintain the stated dividend, but sustainable distributions ultimately require the large construction pipeline to begin contributing incremental free cash flow.

Risk Assessment

Business risks include Vinyl Acetate, the core earnings segment, recorded a 15.0% year-on-year decline in segment profit despite 7.3% sales growth, indicating margin, mix, pricing, or input-cost sensitivity in the largest profit pool., Chemical-manufacturing demand is exposed to global industrial production, customer destocking, raw-material and energy-price volatility, and foreign-exchange movements., Annualized DIO alerts of 165 days and 107 days, together with a 209-day cash conversion cycle, create risk of inventory overhang and delayed conversion of sales into cash., Construction in progress of ¥116.9bn, 20.4% of PPE, creates execution risk around project timing, cost control, commissioning, utilization, and the achievement of targeted returns., The full-year operating-income forecast requires ¥41.2bn in the second half, higher than first-half operating income of ¥28.8bn, increasing exposure to end-market and margin assumptions..

Financial risks include Debt/EBITDA of 3.27x is manageable but elevated relative to the 2.5x investment-grade reference, while loans increased materially year on year to fund investment., The tax-burden alert is material: a 0.580 tax burden and 38.1% effective tax rate suppress the conversion of pre-tax profit into shareholder earnings., First-half free cash flow of ¥3.0bn did not cover the approximately ¥9.7bn interim dividend, and dividend plus buybacks of approximately ¥19.7bn exceeded first-half net income., Capital efficiency is weak, with the ROIC alert at 4.1%, below the 5% warning threshold; this indicates that the current asset and investment base is not yet earning an adequate return..

Key concerns include Priority 1: Improve ROIC through higher utilization, segment-margin recovery, and disciplined returns from the construction pipeline., Priority 2: Reduce receivable and inventory days to shorten the 209-day cash conversion cycle and restore free-cash-flow headroom., Priority 3: Deliver the forecasted second-half earnings acceleration without further SG&A deleveraging or increased debt dependence., Priority 4: Preserve financial flexibility as capital expenditure, dividends, and repurchases compete for cash..

Investment Implications

Key takeaways include First-half revenue and operating-profit growth were positive, with operating margin improving 10bp to 6.7%., Functional Materials, Isoprene, and Fibers delivered strong earnings improvement, while the profit decline in core Vinyl Acetate remains the principal operating issue., Cash earnings conversion is strong, but free cash flow is constrained by ¥56.0bn of investing outflow., Liquidity and interest coverage are strong, while debt/EBITDA and debt growth warrant monitoring during the investment cycle., The reported 4.1% ROIC and annualized 3.7% ROE remain below common capital-efficiency thresholds..

Metrics to watch include Vinyl Acetate segment margin and profit recovery, Functional Materials sales growth and segment-margin sustainability, Second-half operating profit versus the ¥41.2bn required to meet full-year guidance, Annualized DSO, DIO, and cash conversion cycle, Construction-in-progress conversion into operating assets and incremental EBITDA, Debt/EBITDA, free cash flow, and total return ratio, Effective tax rate and tax burden.

Regarding relative positioning, Kuraray combines strong liquidity, moderate balance-sheet leverage, and a diversified specialty-materials portfolio with below-benchmark capital efficiency and unusually working-capital-intensive cash conversion. Its low goodwill exposure is favorable versus acquisition-heavy peers, but the current investment program must translate into higher utilization and margins for returns to improve materially.